In a separate analysis of patients with Parkinson’s disease only, the addition of between subject clinical variables revealed no significant effect of UPDRS-III [F(3,117) = 3.827; not significant], LEDD, duration, COMT, MAPT or APOE genotype (all F < 1). The gene discussed is COMT; the disease is Parkinson disease.